Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 8/20 | 0.38 |
| ▸ | CES1 | P23141 | 5/20 | 0.38 |
| ▸ | CES2 | O00748 | 2/20 | 0.38 |
| ▸ | NAAA | Q02083 | 1/20 | 0.38 |
| ▸ | DGKA | P23743 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | HTR2C | P28335 | 1/20 | 0.35 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.35 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.35 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29025182 | 0.80 | NAAA (0.44) | FAAHNAAAMEN1KMT2AEPHX1 | |
| SCHEMBL918326 | 0.80 | NAAA (0.44) | FAAHNAAAMEN1KMT2AEPHX1 | |
| SCHEMBL10612416 | 0.80 | NAAA (0.44) | FAAHNAAAMEN1KMT2AEPHX1 | |
| SCHEMBL3208393 | 0.77 | NAAA (0.42) | FAAHNAAAMEN1KMT2AEPHX1 | |
| SCHEMBL28211894 | 0.75 | FAAH (0.46) | FAAHCES1CES2NAAADGKA | |
| SCHEMBL7786543 | 0.75 | FAAH (0.46) | FAAHCES1CES2NAAADGKA | |
| SCHEMBL5530059 | 0.74 | FAAH (0.44) | FAAHCES1CES2NAAADGKA | |
| SCHEMBL5665790 | 0.71 | NAAA (0.48) | FAAHNAAADGKAMEN1KMT2A | |
| SCHEMBL9723686 | 0.71 | FAAH (0.48) | FAAHCES1CES2NAAADGKA | |
| SCHEMBL27562251 | 0.70 | FAAH (0.43) | FAAHCES1CES2NAAADGKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11931447-B2 | Polymer/hydrophilic silica oil blend | DOW GLOBAL TECHNOLOGIES LLC (US) | 2024-03-19 | — | — | US | disclosed |
| US-20220160596-A1 | HYDROPHILIC SILICA/POLYMER BLEND | DOW GLOBAL TECHNOLOGIES LLC | 2022-05-26 | — | — | US | disclosed |
| US-20220142903-A1 | POLYMER/HYDROPHILIC SILICA OIL BLEND | ROHM AND HAAS COMPANY | 2022-05-12 | — | — | US | disclosed |
| EP-3638202-B1 | OIL CLEANSER COMPOSITION | DOW GLOBAL TECHNOLOGIES LLC (US) | 2021-09-15 | — | — | EP | disclosed |
| US-20210196593-A1 | POLYACRYLATE OIL GEL COMPOSITION | DOW GLOBAL TECHNOLOGIES LLC (US) | 2021-07-01 | — | — | US | disclosed |
| US-10864155-B2 | Oil cleanser composition | DOW GLOBAL TECHNOLOGIES LLC (US) | 2020-12-15 | — | — | US | disclosed |
| WO-2020223026-A1 | POLYMER/HYDROPHILIC SILICA OIL BLEND | DOW GLOBAL TECHNOLOGIES LLC (US) | 2020-11-05 | — | — | WO | disclosed |
| WO-2020223024-A1 | HYDROPHILIC SILICA/POLYMER BLEND | DOW GLOBAL TECHNOLOGIES LLC (US) | 2020-11-05 | — | — | WO | disclosed |
| US-20200138689-A1 | OIL CLEANSER COMPOSITION | DOW GLOBAL TECHNOLOGIES LLC | 2020-05-07 | — | — | US | disclosed |
| US-10632059-B2 | Non-aqueous compositions of polymers derived from monomers having acryloyl moiety and lactam moiety and applications thereof | ISP INVESTMENTS LLC (US) | 2020-04-28 | — | — | US | disclosed |
| US-7416739-B2 | Composition and process for retaining active ingredients | ROHM AND HAAS COMPANY (US) | 2008-08-26 | — | — | US | disclosed |
| EP-1273635-B1 | Water resistant polymer network compositions | ROHM & HAAS (US) | 2007-11-14 | — | — | EP | disclosed |
| US-20030022981-A1 | Water resistant compositions that retain active components and process | BAXTER STEVEN M (US) | 2003-01-30 | — | — | US | disclosed |
| US-20030021847-A1 | Composition and process for retaining active ingredients | HERCULES LLC | 2003-01-30 | — | — | US | disclosed |
| EP-1273286-A2 | Composition and process for retaining active ingredients | Rohm and Haas (US) | 2003-01-08 | — | — | EP | disclosed |
| EP-1273635-A2 | Water resistant polymer network compositions | Rohm and Haas Company (US) | 2003-01-08 | — | — | EP | disclosed |
| EP-0356196-B1 | Cosmetic preparation | DENTO MED IND INC (US) | 1993-10-27 | — | — | EP | disclosed |
| US-5039516-A | Containing homopolymers of 2-hydroxyethyl methacrylate | DENTO-MED INDUSTRIES, INC. (US) | 1991-08-13 | — | — | US | disclosed |
| EP-0356196-A2 | Cosmetic preparation | DENTO-MED INDUSTRIES, INC. (US) | 1990-02-28 | — | — | EP | disclosed |
| US-4883659-A | AMMONIUM SALT OF FATTY ACID, POLYHYDROXYETHYL METHACRYLATE, SOLVENTS | DENTO-MED INDUSTRIES, INC. (US) | 1989-11-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11931447-B2 | Polymer/hydrophilic silica oil blend | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, C9, MMS19 | FAAH 2325/4885CES1 2913/4885CES2 2804/4885 |
| US-20220160596-A1 | HYDROPHILIC SILICA/POLYMER BLEND | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, C9, CD44 | FAAH 2782/4885CES1 3894/4885CES2 3146/4885 |
| US-10632059-B2 | Non-aqueous compositions of polymers derived from monomers having acryloyl moiety and lactam moiety and applications thereof | C9, PARG, C5 | FAAH 1121/4885CES1 2276/4885CES2 1562/4885 |
| US-20220142903-A1 | POLYMER/HYDROPHILIC SILICA OIL BLEND | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, C9, MMS19 | FAAH 2325/4885CES1 2913/4885CES2 2804/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.